Abstract: Processes for quantifying an amount of functional groups immobilized on a solid support are described herein. The processes allow for determining whether sufficient functional groups are provided on a solid support for the attachment of a first binding pair member for the detection of a target analyte.
Type:
Grant
Filed:
September 27, 2021
Date of Patent:
March 21, 2023
Assignee:
Siemens Healthcare Diagnostics Inc.
Inventors:
Spencer Lin, Christopher Reamer, Ryan Spears
Abstract: Disclosed herein are methods for using modified liposomes or carrier proteins comprising (i) an acridinium ester (AE), and (ii) a first agent encapsulated by the liposomes and/or (iii) a second agent on the surface of the liposomes or the carrier proteins. Specifically, the disclosed methods provide methods of labeling a target of interest, assaying a biological sample for a target antigen, and detecting a target antigen in a biological sample. Further disclosed herein are methods for increasing the strength of a signal detected by an imaging modality.
Abstract: Methods for image-based detection of the tops of sample tubes used in an automated diagnostic analysis system may be based on a convolutional neural network to pre-process images of the sample tube tops to intensify the tube top circle edges while suppressing the edge response from other objects that may appear in the image. Edge maps generated by the methods may be used for various image-based sample tube analyses, categorizations, and/or characterizations of the sample tubes to control a robot in relationship to the sample tubes. Image processing and control apparatus configured to carry out the methods are also described, as are other aspects.
Type:
Grant
Filed:
June 25, 2018
Date of Patent:
March 7, 2023
Assignee:
Siemens Healthcare Diagnostics Inc.
Inventors:
Yao-Jen Chang, Stefan Kluckner, Benjamin S. Pollack, Terrence Chen
Abstract: In one aspect of the present disclosure, a tissue marking system is provided that includes a container and an applicator. The applicator is in the container and is removable therefrom. The applicator includes a tip, a reservoir containing sterile tissue marking dye, and a valve. The valve is configured to open and permit sterile tissue marking dye to flow from the reservoir to the tip of the applicator in response to the tip being pressed against a priming surface. In one embodiment, the system includes a substrate that is removable from the container and includes the priming surface. In another embodiment, the container includes a tray having a compartment that receives the applicator. The tray includes a well that includes the priming surface.
Abstract: The invention provides methods for determining the MSI status of a patient by liquid biopsy with sample preparation using hybrid capture and non-unique barcodes. In certain aspects, the invention provides a method of detecting microsatellite instability (MSI). The method includes obtaining cell-free DNA (cfDNA) from a sample of blood or plasma from a patient and sequencing portions of the cfDNA to obtain sequences of a plurality of tracts of nucleotide repeats in the cfDNA. A report is provided describing an MSI status in the patient when a distribution of lengths of the plurality of tracts has peaks that deviate significantly from peaks in a reference distribution.
Abstract: Negative outcomes experienced by a user in a live software system can be automatically, deterministically, and contemporaneously traced back to the root conditions that caused those outcomes, by generating causal event entries in a database for those root conditions as they occur, assigning unique causal IDs to those causal events, and propagating causal IDs alongside the software system state changes that are known to produce negative outcomes and which are effected by those root conditions. By selectively passing causal IDs based on the input and output values of the operation, subsequent causal events and negative outcomes can be linked accurately to causal IDs of parent events, making it simpler to trace negative outcomes for the user back to their root cause events in a software system.
Abstract: An optical discrimination apparatus adapted for use in PCR testing and the like. The apparatus includes a multi-color light emitter to emit excitation light, a sample holder configured to hold dye-marked nucleic acid fragments in a PCR solution at a position configured to receive the excitation light along a first direction, light emission collection optics configured to collect scattered excitation light and light emission (fluorescent emission) from the sample holder along a second direction that is approximately orthogonal to the first direction, a spectrally-dispersive element configured to spectrally disperse scattered light and emission light, and a spectral detector configured to receive the separated emission light and excitation light on different photosites of the spectral detector. Systems and methods are provided, as are other aspects.
Type:
Application
Filed:
February 17, 2021
Publication date:
March 2, 2023
Applicant:
Siemens Healthcare Diagnostics Inc.
Inventors:
Mohiudeen Azhar, Paul Patt, Ragavendar Madrassethuraman, Karan Mohan
Abstract: Methods and reagents are disclosed for minimizing a false result in an assay measurement for determining a concentration of an analyte in a sample suspected of containing the analyte. The method comprises pretreating both an antibody and a sample to be subjected to a non-agglutination immunoassay. In the method the antibody and the sample are combined with a pretreatment agent selected from the group consisting of hydroxyphenyl-substituted C1-C5 carboxylic acids and metallic salts thereof and halogen-substituted C1-C5 carboxylic acids and metallic salts thereof in an amount effective to enhance the accuracy of the non-agglutination immunoassay.
Abstract: An apparatus, vortex generator assembly and method for automated cell lysis and nucleic acid purification and processing. The vortex generator assembly includes sample holder having a lysis well, at least one wash well, and an elution well. The vortex generator assembly also includes a sample holder cover having a plurality of vibration rods for creating a vortex in the wells of the sample holder. The apparatus includes motor operating a rotating cam to cause the vibration rods to vibrate and create the vortex in a well holding fluid and magnetic beads, wherein the vortexing speed is sufficient to overcome the magnetic attraction between the beads and disperse the beads in solution, to collect nucleic acids such as DNA.
Abstract: A sample holder for PCR processing. The sample holder includes a body with an inlet and outlet grooves formed alongside each other, a detection recess that is connected to the inlet and outlet grooves, and a fill port interconnected to both the inlet and outlet grooves, and a cover interfacing with the body to form an inlet channel interconnected to the fill port, a detection region interconnected to the inlet channel, and an outlet channel interconnected to the detection region and the fill port. The detection region is configured to receive a PCR solution from the fill port and replication occurs within the detection region via heating and cooling cycles. Thereafter, fluorescent emissions from tagged replicated DNA/RNA in the detection region are detected and measured. PCR stations, PCR station assemblies, PCR testing systems, and methods of operating a PCR testing systems are provided, as are other aspects.
Type:
Application
Filed:
February 8, 2021
Publication date:
February 23, 2023
Applicant:
Siemens Healthcare Diagnostics Inc.
Inventors:
Daniel CHU, Paul PATT, Garret BAUTISTA, David John GUCKENBERGER, JR.
Abstract: An automated method and system for determining the risk of developing a cancer in a subject, the method comprising preparing a tissue sample obtained from the subject for visually identifying at least one biological marker associated with the cancer, digitally scanning the prepared tissue sample, analyzing the scanned image of the tissue sample to identify regions of interest, quantifying at least one parameter associated with the marker, and executing an algorithm using the quantified parameter to calculate a risk score, wherein the risk score is representative of the risk of the individual developing the cancer.
Type:
Grant
Filed:
March 14, 2017
Date of Patent:
February 21, 2023
Assignee:
Proteocyte Diagnostics Inc.
Inventors:
Ying Gu, Jason T. K. Hwang, Kenneth P. H. Pritzker, Ranju Ralhan, Mi Shen
Abstract: Devices, methods, and kits for detecting at least two analytes present within a small volume single fluid sample obtained from patient for the creation of a multiplexed panel of the various analytes present within the single fluid sample are disclosed.
Abstract: A system for transporting a sample in a clinical analysis system includes a sample container holding the sample, a ferromagnetic base connected to a bottom portion of the sample container, and a puck. The puck is used for transporting the sample container in the clinical analysis system. The puck comprises an embedded magnet for securing the sample container to the puck using the ferromagnetic base.
Abstract: Multi-use biosensors are disclosed that include enzymes coupled to nanobeads; the multi-use biosensors are used to detect analytes in fluidic biological samples, and the biosensors also maintain their enzyme activity after many uses. Multi-sensor arrays are disclosed that include multiple biosensors. Also disclosed are methods of producing and using these devices.
Abstract: A method for backlash compensation in motion control systems includes homing a payload of a motion control system, and performing a tooth-pitch non-uniformity procedure on the motion control system to identify a non-uniformity correction. A backlash lookup table is generated for use in backlash correction during normal operation of the motion control system. The backlash lookup table is generated using a training process that includes selecting a move sequence for operating the motion control system, and executing the move sequence with the non-uniformity correction. The training process further includes computing a backlash measurement describing backlash of one or more components of the motion control system during the move sequence, and storing the backlash measurement in the backlash lookup table.
Type:
Application
Filed:
January 15, 2021
Publication date:
February 9, 2023
Applicant:
Siemens Healthcare Diagnostics Inc.
Inventors:
Narayanan Ramakrishnan, Omar Khalaf, David G. Henderson
Abstract: Compositions, kits, and methods for performing rapid polymerase chain reaction (PCR) to amplify a target nucleic acid in a biological sample are disclosed. The methods include the use of at least one hybridization stabilizer and/or the adjustment of the thermocycling profiles between initiation and propagation phases of the amplification process. Also disclosed are methods of detecting the target nucleic acid following amplification thereof, as well as reaction mixtures that may be utilized in said methods.
Abstract: Liquid supply system for an analyzer. Liquid supply system includes a liquid-containing container and a spout support tool. Liquid-containing container is made up of a rectangular parallelepiped box comprising a wall with an opening therein, and a collapsible insert including a liquid-containing portion received inside the rectangular parallelepiped box. The collapsible insert includes a spout with a flange wherein both are retractable through the opening. The support tool has a body having an engaging portion and a grasping portion, the engaging portion includes a first engagement surface engaged with a surface of the wall, a second engagement surface, and a spout receiver formed in the engaging portion that is configured to be received under the flange to support the spout. pout support tools and retaining methods of a liquid supply system are provided, as are other aspects.
Abstract: Methods of visualizing performance of a diagnostic laboratory system are provided. The methods include displaying on a display, an image representing a layout of a plurality of laboratory analyzers included within the diagnostic laboratory system, and overlaying the image with a dynamically-changeable color overlay that indicates a performance for the plurality of laboratory analyzers over a period of time via using changeable colors. Systems including color-changeable overlays are provided as are other aspects.
Abstract: Aspects described herein provide methods and kits for identifying at least one methylation pattern and optionally a transcription pattern in a nucleic acid from at least one exosome or circulating tumor cell in blood or other tissue sample.
Type:
Application
Filed:
July 5, 2019
Publication date:
January 26, 2023
Applicant:
Active Genomes Expressed Diagnostics, Inc